Skip to content
10-Q

Quarterly Report

Core Scientific, Inc./tx CORZ CORZR CORZW CORZZ

0001628280-26-031396

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 317.89M sh
Shares Diluted Q1 2026 · Mar 31, 2026 322.91M sh
Capex Q1 2026 · Mar 31, 2026 $389.23M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $249.88M
Long Term Debt Q1 2026 · Mar 31, 2026 $1.06B
Long Term Debt Q1 2026 · Dec 31, 2025 $1.06B
Short Term Debt Q1 2026 · Mar 31, 2026 $993.94M
Short Term Debt Q1 2026 · Dec 31, 2025 $0
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.01B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $311.38M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$1.31B
Stockholders Equity Q1 2026 · Dec 31, 2025 −$962.74M
Current Liabilities Q1 2026 · Mar 31, 2026 $2.66B
Current Liabilities Q1 2026 · Dec 31, 2025 $781.4M
Total Liabilities Q1 2026 · Mar 31, 2026 $4.38B
Total Liabilities Q1 2026 · Dec 31, 2025 $3.31B
Current Assets Q1 2026 · Mar 31, 2026 $1.45B
Current Assets Q1 2026 · Dec 31, 2025 $895.54M
Total Assets Q1 2026 · Mar 31, 2026 $3.07B
Total Assets Q1 2026 · Dec 31, 2025 $2.35B
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.06
Eps Basic Q1 2026 · Mar 31, 2026 −$1.06
Sga Expense Q1 2026 · Mar 31, 2026 $44.85M
Net Income Q1 2026 · Mar 31, 2026 −$347.19M
Operating Income Q1 2026 · Mar 31, 2026 −$310.42M
Gross Profit Q1 2026 · Mar 31, 2026 $30.11M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $85.14M
Revenue Q1 2026 · Mar 31, 2026 $115.24M